Sellas Life Sciences
SLS
#9275
Rank
โ‚ฌ60.33 M
Marketcap
0,86ย โ‚ฌ
Share price
2.09%
Change (1 day)
-16.61%
Change (1 year)

P/E ratio for Sellas Life Sciences (SLS)

P/E ratio as of December 2024 (TTM): -0.5688

According to Sellas Life Sciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.568839. At the end of 2022 the company had a P/E ratio of -1.06.

P/E ratio history for Sellas Life Sciences from 2008 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.06-74.55%
2021-4.1652.43%
2020-2.731269.58%
2019-0.1992-34.1%
2018-0.3022-52.25%
2017-0.6329-21.7%
2016-0.8083-77.45%
2015-3.59-28.77%
2014-5.03-13.74%
2013-5.84151.72%
2012-2.3255.37%
2011-1.49-62.2%
2010-3.956.39%
2009-3.71-31.44%
2008-5.41

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-3.78 565.28%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.